The Life Sciences team advised Paindrainer AB on its commercial partnership agreement with Dr. Edward Rubin, past President of The New York Society of Interventional Pain Physicians.
This strategic collaboration accomplishes a crucial milestone, allowing Paindrainer AB access to the U.S. market with its groundbreaking FDA registered Medical Device Class I digital solution for chronic pain management.
Paindrainer AB is the first evidence based digital tool demonstrating improved quality of life in patients suffering from chronic pain. The solution is powered by leveraging advanced algorithms and is fully adaptive to each individual patient, a unique feature called the 360° patient-centricity concept. Paindrainer PD1 is an FDA registered Class I Medical Device.
The Goodwin team was led by Jonathan Ishee and Kristopher Brown.
For additional details on the partnership, please read the press release.